BioCentury | Oct 15, 2018
Company News

New CEO Forster eyes capital raise for F-star

...Novo Holdings A/S (Hellerup, Denmark), SR One, Aescap Venture Management, MP Healthcare Venture Management and MS Ventures...
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...the size of its fund from €150 million to €300 million when it transitioned from MS Ventures...
...company RaNA Therapeutics Inc. , and notable leveragable single asset investments include Calypso Biotech S.A. MS ventures...
BioCentury | Feb 7, 2017
Financial News

Prexton raises EUR 29M in series B round

...round co-led by Forbion Capital Partners and Seroba Life Sciences. Also participating were prior investors MS Ventures...
BioCentury | Jun 13, 2016
Finance

Venture double-double

...development team. The strategic investor, which is changing its name to Merck Ventures B.V. from MS Ventures...
...plus €10 million for an Israeli start-up incubator. At the time of the 2013 expansion, MS Ventures'...
...for $375 million in additional development and regulatory milestones. Atlas Venture seeded the company, and MS Ventures...
BioCentury | Apr 11, 2016
Financial News

Metabomed financial update

...million. New investors Pfizer Inc. (NYSE:PFE, New York, N.Y.) and Arkin Holdings joined existing investors MS Ventures...
BioCentury | Apr 5, 2016
Financial News

Metabomed caps $18M series A

...$18 million. New investors Pfizer Inc. (NYSE:PFE) and Arkin Holdings participated, as did existing investors MS Ventures...
...cancer cells. MS Ventures was Metabomed's seed investor. Simone Botti will resign as head of the MS Ventures...
BioCentury | Mar 28, 2016
Finance

Padded coffers

...was joined by the Johnson & Johnson Innovation-JJDC venture arm of Johnson & Johnson (NYSE:JNJ), MS Ventures...
BioCentury | Mar 24, 2016
Top Story

BMS acquiring Padlock

...A investors included the Johnson & Johnson Innovation-JJDC venture arm of Johnson & Johnson (NYSE:JNJ), MS Ventures...
BioCentury | Dec 21, 2015
Financial News

Inthera Bioscience completes venture financing

...Switzerland Business: Cancer Date completed: 2015-12-15 Type: Venture financing Raised: EUR3.4 million ($3.7 million) Investors: MS Ventures...
BioCentury | Dec 7, 2015
Financial News

ObsEva completes venture financing

...Investments; New Enterprise Associates; OrbiMed Advisors; Rock Springs Capital; Sofinnova Partners; Sofinnova Ventures; Novo Ventures; MS Ventures WIR...
Items per page:
1 - 10 of 57
BioCentury | Oct 15, 2018
Company News

New CEO Forster eyes capital raise for F-star

...Novo Holdings A/S (Hellerup, Denmark), SR One, Aescap Venture Management, MP Healthcare Venture Management and MS Ventures...
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...the size of its fund from €150 million to €300 million when it transitioned from MS Ventures...
...company RaNA Therapeutics Inc. , and notable leveragable single asset investments include Calypso Biotech S.A. MS ventures...
BioCentury | Feb 7, 2017
Financial News

Prexton raises EUR 29M in series B round

...round co-led by Forbion Capital Partners and Seroba Life Sciences. Also participating were prior investors MS Ventures...
BioCentury | Jun 13, 2016
Finance

Venture double-double

...development team. The strategic investor, which is changing its name to Merck Ventures B.V. from MS Ventures...
...plus €10 million for an Israeli start-up incubator. At the time of the 2013 expansion, MS Ventures'...
...for $375 million in additional development and regulatory milestones. Atlas Venture seeded the company, and MS Ventures...
BioCentury | Apr 11, 2016
Financial News

Metabomed financial update

...million. New investors Pfizer Inc. (NYSE:PFE, New York, N.Y.) and Arkin Holdings joined existing investors MS Ventures...
BioCentury | Apr 5, 2016
Financial News

Metabomed caps $18M series A

...$18 million. New investors Pfizer Inc. (NYSE:PFE) and Arkin Holdings participated, as did existing investors MS Ventures...
...cancer cells. MS Ventures was Metabomed's seed investor. Simone Botti will resign as head of the MS Ventures...
BioCentury | Mar 28, 2016
Finance

Padded coffers

...was joined by the Johnson & Johnson Innovation-JJDC venture arm of Johnson & Johnson (NYSE:JNJ), MS Ventures...
BioCentury | Mar 24, 2016
Top Story

BMS acquiring Padlock

...A investors included the Johnson & Johnson Innovation-JJDC venture arm of Johnson & Johnson (NYSE:JNJ), MS Ventures...
BioCentury | Dec 21, 2015
Financial News

Inthera Bioscience completes venture financing

...Switzerland Business: Cancer Date completed: 2015-12-15 Type: Venture financing Raised: EUR3.4 million ($3.7 million) Investors: MS Ventures...
BioCentury | Dec 7, 2015
Financial News

ObsEva completes venture financing

...Investments; New Enterprise Associates; OrbiMed Advisors; Rock Springs Capital; Sofinnova Partners; Sofinnova Ventures; Novo Ventures; MS Ventures WIR...
Items per page:
1 - 10 of 57